Zydus Cadila gets USFDA nod for antihistamine drug Ruby Khatun Khatun24 May 2017 9:04 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market antihistamine Cyproheptadine Hydrochloride...
DSM Sinochem Pharmaceuticals Wins Indian Patent Infringement Case Ruby Khatun Khatun23 May 2017 1:27 PM ISTSINGAPORE: DSM Sinochem Pharmaceuticals (DSP), the global leader in production and commercialization of sustainable, enzymatic antibiotics, next...
Regeneron, Sanofi rheumatoid arthritis drug wins USFDA approval Ruby Khatun Khatun23 May 2017 1:23 PM ISTThe U.S. Food and Drug Administration approved Regeneron Pharmaceuticals and Sanofi's biotech drug for adults with moderate to severe rheumatoid...
AstraZeneca sells ageing beta-blocker to Recordati for $300 mln Ruby Khatun Khatun23 May 2017 1:23 PM ISTLONDON: AstraZeneca has sold the European rights to its ageing beta-blocker heart drug Seloken to Italy's Recordati for $300 million, as part of a...
Causing Pollution: NGT slaps Rs 15 lakh fine on Teva API India Ruby Khatun Khatun23 May 2017 1:23 PM ISTNew Delhi: The National Green Tribunal slapped a fine of Rs 15 lakh on a pharmaceutical unit in Uttar Pradesh for discharging untreated effluents in...
Lupin gets CDSCO approval for anti-allergy drug Ruby Khatun Khatun23 May 2017 1:22 PM ISTNew Delhi: Drug firm Lupin said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for Bepotastine tablets used in...
Celgene MS drug clears key trial, but disability data falls short Ruby Khatun Khatun23 May 2017 9:07 AM ISTCelgene Corp's multiple sclerosis drug met the main goal of reducing annualized relapse rate, compared with Biogen Inc's Avonex, in a second...
Divis Laboratories explosion: One dead and another sustains serious burns Ruby Khatun Khatun22 May 2017 5:42 PM ISTVisakhapatnam: In an explosion at the dumping yard of the Divis Laboratories, one worker died and another sustained serious burns while segregating...
Higher rate of heart problems seen with Amgen bone drug in trial Ruby Khatun Khatun22 May 2017 12:17 PM ISTAmgen Inc and UCB SA said on Sunday they did not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of...
Natco Pharma gets green nod for Rs 480 crore expansion project Ruby Khatun Khatun22 May 2017 12:03 PM ISTNew Delhi: Natco Pharma has received environment clearance (EC) for its Rs 480 crore expansion project in Telangana that would generate 1,500 jobs.The...
Abbott India Q4 net dips 29 per cent to Rs 42 crore Ruby Khatun Khatun21 May 2017 10:40 AM ISTNew Delhi: Pharma firm Abbott India on Friday reported a 28.69 per cent plunge in standalone net profit to Rs 42.06 crore for the fourth quarter ended...
Pfizer drug from Medivation deal shows promise in breast cancer: study Ruby Khatun Khatun21 May 2017 9:42 AM ISTA breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior...
